HHL-B:CA:TSX-Harvest Healthcare Leaders Income ETF (CAD)

ETF | Others |

Last Closing

CAD 9.05

Change

0.00 (0.00)%

Market Cap

N/A

Volume

708.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

N/A

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.02 (+0.04%)

CAD 4.87B
PHYS-U:CA Sprott Physical Gold Trust

-0.28 (-1.56%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.94 (+1.48%)

CAD 4.54B
HXT-U:CA Horizons S&P/TSX 60 Index ETF

+0.53 (+1.31%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

N/A

CAD 3.78B
XEQT:CA iShares Core Equity Portfolio

+0.29 (+0.98%)

CAD 3.29B
PSLV-U:CA Sprott Physical Silver Trust

-0.12 (-1.33%)

CAD 3.29B
IGAF:CA IA Clarington Loomis Global Al..

N/A

CAD 3.23B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.14 (+0.65%)

CAD 2.78B

ETFs Containing HHL-B:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.97% 69% C- 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.97% 68% D+ 59% D-
Trailing 12 Months  
Capital Gain 2.26% 40% F 47% F
Dividend Return 0.66% 30% F 9% A-
Total Return 2.92% 39% F 42% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.76% 61% D- 50% F
Dividend Return 1.81% 61% D- 44% F
Total Return 0.05% 53% F 11% F
Risk Return Profile  
Volatility (Standard Deviation) 4.17% 80% B- 92% A
Risk Adjusted Return 43.49% 78% C+ 70% C-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:

There is nothing we particularly dislike